eMAR vs Paper MAR Sheets: What CQC Actually Expects in 2025

What CQC actually looks for in medication records

CQC's position is clear: they do not specify which format medication administration records must take. What they do specify — through their inspection framework and published guidance — is what those records must achieve:

• Accurate. Each medication entry must correctly reflect what happened — medication name, dose, time, route of administration, and outcome (given, refused, or withheld with documented reason).
• Complete. Every scheduled medication must have an entry for every visit. Blank spaces are not acceptable unless accompanied by a documented explanation.
• Consistently maintained. Records must follow the same standard across all carers, all clients and all visits — not just when management is watching.
• Auditable. It must be possible to trace who administered what, when, and with what outcome. For controlled drugs, a second witness signature is required.

The question, then, is not "eMAR or paper?" The question is: which format makes it easier to meet all four requirements — consistently, across every visit, every day?

eMAR vs Paper MAR: at a glance

Before going deeper, here is how the two approaches compare across the requirements CQC inspectors actually test against:

Where paper MAR sheets fall short

Paper MAR sheets are not inherently inadequate. A well-designed paper system, used consistently by trained staff, can satisfy CQC's requirements. The problem is the word "consistently."

In practice, paper MAR sheets are prone to several failure modes that are extremely difficult to eliminate:

Blank entries

When medication is not administered, carers should document why — refused by the client, not stocked, medical instruction. On paper, the path of least resistance is to leave the box blank. Blank boxes are one of the most common Safe failures cited in CQC domiciliary care inspection reports.

Illegible entries and back-filling

Paper entries are often completed in poor lighting, at speed, by staff with varying levels of written literacy. Illegible signatures, ambiguous timestamps, and entries completed after the fact ("back-filling") are all common — and all problematic under inspection.

No real-time oversight

With paper MAR sheets, you have no visibility of what's happening until the carer returns the sheet — which may be days later. A missed dose on Monday isn't discovered until the weekly paper round. By then, the client may have been without important medication for multiple visits.

Physical loss or damage

MAR sheets stored at client homes can be lost, damaged, soaked in a spill or taken when a client moves. No paper record survives these events; no digital record is stored only on paper.

How eMAR addresses each failure mode

Electronic MAR systems don't just digitise the paper form. They structurally prevent the most common paper failures:

Controlled drugs and PRN medication: where the gap widens

The four failure modes described above apply across all medication types. But controlled drugs and PRN (as needed) medication expose an even sharper gap between paper and eMAR — because both require additional layers of documentation that paper handles badly.

Controlled drugs: the second witness problem

Regulations require a second witness signature whenever a controlled drug is administered. On paper, this means a second person must be physically present, observe the administration, and sign the same MAR sheet. In domiciliary care — where carers typically work alone — this creates a practical problem. Agencies develop workarounds: phone witnesses, retrospective countersignatures, or senior staff signing off in bulk at the end of a run. None of these is compliant, and all of them are visible to an inspector reading the paperwork.

eMAR handles this differently. A digital witnessed administration entry requires two authenticated logins — the administering carer submits the record, and a second registered user confirms it within the system. Both identities are logged, timestamped, and permanently attached to the record. There is no ambiguity about who witnessed what, or when.

PRN medication: no prompt, no record

PRN medication is administered at the carer's discretion, when a client's condition requires it — pain relief, anti-anxiety medication, antiemetics. On paper, carers must independently decide whether to administer, record that they did, write the reason, and note the outcome. There is no prompt, no mandatory field, and no way of knowing whether a carer even considered the medication if it was not administered. In practice, PRN records on paper are inconsistent at best and absent at worst.

eMAR systems prompt the carer explicitly for each PRN medication on the care plan. If they administer, they must record the reason code (pain score, symptom description, or similar). If they do not administer, they still record why — "client declined", "symptom not present", or another reason from a structured list. The result is a complete PRN history that a clinician or inspector can read and understand without guesswork.

Stock counting and the CD register

Controlled drug stock must be counted and reconciled against administration records. On paper, this reconciliation is entirely manual: someone must physically count the remaining tablets, cross-reference the CD register, and calculate whether the numbers add up. The process is time-consuming, error-prone, and typically done infrequently. Discrepancies that emerge only at a monthly stock check may represent weeks of missing or unrecorded administrations.

eMAR can flag stock discrepancies in near real time. Each administration reduces the expected stock count; if physical stock does not match expected stock, the system raises an alert. This is precisely the cross-reference a CQC inspector will perform when they arrive on site — comparing the CD register with the MAR sheet for the same medication, the same client, over the same period. Any discrepancy is treated as a serious finding. eMAR makes that discrepancy visible before the inspector does.

What a CQC inspection actually looks at — MAR records in practice

It is worth being specific about what an inspection involves, because the common mental model — "inspectors check that records exist" — misses most of what actually happens. Inspectors do not just confirm that MAR sheets are present. They trace individual medication journeys.

The end-to-end trace

A CQC inspector will typically select a small number of clients and follow their medication from the care plan and prescription through to each individual administration entry. They are looking for coherence: does the MAR sheet reflect what the care plan says? Does the care plan match what the GP or pharmacist prescribed? Are the doses, times and routes consistent across all three documents? Inconsistencies — even minor ones that happen to have an innocent explanation — require documentation. Unexplained inconsistencies are findings.

They will look for gaps in the record: missed visits with no documented reason, stretches of dates with no entries, medication that appears in the care plan but nowhere on the MAR. They will check whether entries that don't match the care plan — a different dose, an unlisted medication — have any supporting documentation. With paper, answering each of these questions means reading through sheets. With eMAR, the same checks take minutes on a screen.

What inspectors ask carers

Inspectors do not just read records — they speak to carers directly. The question "What do you do when a client refuses medication?" is almost routine. A carer who answers clearly — "I record it as refused on the app, select the reason, and let the office know if it happens twice" — demonstrates both knowledge and a functioning system. A carer who says "I just leave it and mention it next time I'm in" — even if they mean well — is a significant red flag, regardless of what the records show.

eMAR makes correct carer behaviour the default. Because the system requires a recorded outcome before the visit can close, carers who use it daily have the right answer ready — because it is simply a description of what the system makes them do. Paper, by contrast, asks carers to exercise discretion and apply training. That works for most carers most of the time. It does not work for all carers all of the time, and an inspector needs it to work for all carers all of the time.

Signing patterns and identity verification

Inspectors will examine who signed what. They are alert to several patterns: the same person signing for visits they could not plausibly have attended; signatures that look identical across different supposed carers; visits signed off by a manager rather than the attending carer; and bulk signing — where multiple entries across multiple days appear to have been completed in a single sitting rather than at the time of each visit.

eMAR eliminates most of these risks structurally. Each submission is tied to a specific user account, authenticated by login credentials, timestamped by the server, and in many implementations geolocated. It is not possible to sign for a visit you did not attend without either sharing your login — which is itself a governance failure — or the location data contradicting the record. The audit trail eMAR creates is device-stamped, identity-verified and immutable. Paper creates none of these assurances.

The cost case for eMAR

Compliance arguments are compelling on their own terms. But for many agency owners, the decision also has to make financial sense. The cost case for eMAR is stronger than it first appears — because the comparison is not just eMAR subscription cost vs. nothing. It is eMAR cost vs. the true cost of running a paper-based medication system.

The transition from paper to eMAR

The most common concern agencies raise about moving to eMAR is staff adoption — particularly older carers who are less comfortable with smartphones. In practice, this is rarely the barrier agencies expect it to be. Modern eMAR apps are designed for carers, not for technology enthusiasts: large buttons, clear instructions, simple workflows.

A realistic transition looks like this:

1. Run paper and eMAR in parallel for 2–4 weeks while staff familiarise themselves with the app.
2. Identify any staff who need additional support and provide it — usually one-to-one, 30-minute sessions.
3. Set a go-live date. On that date, paper MAR is retired for eMAR.
4. Review the first month's records for completion rates and any error patterns.

Most agencies that have made this transition report that the changeover was significantly smoother than they expected — and that the compliance improvement was immediately visible.

The bottom line

CQC doesn't require eMAR. But CQC does require accurate, complete, consistently maintained and auditable medication records. Paper MAR sheets can theoretically meet this standard. In practice, eMAR meets it more reliably — because the system enforces the standard rather than depending on individual carers to uphold it on every visit.

If your paper MAR records are consistently excellent, there is no regulatory imperative to change. If you have ever had a blank entry, a back-filled timestamp or a missing signature, eMAR removes the root cause of those failures.

To see how iStaffRota's eMAR module works in practice, book a short demo — we'll show you the carer experience and the management audit view side by side.